30 related articles for article (PubMed ID: 31064214)
1. Comment on "Role of increased plasminogen activator inhibitor-1 and vitronectin in gestational diabetes mellitus".
Yin H; Shi R
Rev Assoc Med Bras (1992); 2024; 70(4):e20231607. PubMed ID: 38716956
[No Abstract] [Full Text] [Related]
2. Plasminogen Activator Inhibitor-1-Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype.
Jung RG; Duchez AC; Simard T; Dhaliwal S; Gillmore T; Di Santo P; Labinaz A; Ramirez FD; Rasheed A; Robichaud S; Ouimet M; Short S; Clifford C; Xiao F; Lordkipanidzé M; Burger D; Gadde S; Rayner KJ; Hibbert B
JACC Basic Transl Sci; 2022 Oct; 7(10):985-997. PubMed ID: 36337926
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.
Frischmuth T; Hindberg K; Aukrust P; Ueland T; Braekkan SK; Hansen JB; Morelli VM
J Thromb Haemost; 2022 Jul; 20(7):1618-1626. PubMed ID: 35289062
[TBL] [Abstract][Full Text] [Related]
4. Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic.
Simard T; Jung RG; Di Santo P; Harnett DT; Abdel-Razek O; Ramirez FD; Motazedian P; Parlow S; Labinaz A; Moreland R; Marbach J; Poulin A; Levi A; Majeed K; Boland P; Couture E; Sarathy K; Promislow S; Russo JJ; Chong AY; So D; Froeschl M; Dick A; Labinaz M; Le May M; Holmes DR; Hibbert B
Mayo Clin Proc Innov Qual Outcomes; 2021 Dec; 5(6):1138-1152. PubMed ID: 34934904
[TBL] [Abstract][Full Text] [Related]
5. Modeling Hypoxic Stress In Vitro Using Human Embryonic Stem Cells Derived Cardiomyocytes Matured by FGF4 and Ascorbic Acid Treatment.
Choi SC; Seo HR; Cui LH; Song MH; Noh JM; Kim KS; Choi JH; Kim JH; Park CY; Joo HJ; Hong SJ; Ko TH; Choi JI; Kim HJ; Kim JH; Paek SH; Park JN; Kim DH; Jang Y; Park Y; Lim DS
Cells; 2021 Oct; 10(10):. PubMed ID: 34685725
[TBL] [Abstract][Full Text] [Related]
6. The secretome of liver X receptor agonist-treated early outgrowth cells decreases atherosclerosis in Ldlr-/- mice.
Rasheed A; Shawky SA; Tsai R; Jung RG; Simard T; Saikali MF; Hibbert B; Rayner KJ; Cummins CL
Stem Cells Transl Med; 2021 Mar; 10(3):479-491. PubMed ID: 33231376
[TBL] [Abstract][Full Text] [Related]
7. Associations of multiple serum biomarkers and the risk of cardiovascular disease in China.
Yao H; Hou C; Liu W; Yi J; Su W; Hou Q
BMC Cardiovasc Disord; 2020 Sep; 20(1):426. PubMed ID: 32993518
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations.
Simard T; Jung R; Labinaz A; Faraz MA; Ramirez FD; Di Santo P; Perry-Nguyen D; Pitcher I; Motazedian P; Gaudet C; Rochman R; Marbach J; Boland P; Sarathy K; Alghofaili S; Russo JJ; Couture E; Promislow S; Beanlands RS; Hibbert B
J Am Heart Assoc; 2019 Aug; 8(15):e012228. PubMed ID: 31379241
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of C-reactive protein after drug-eluting stent implantation: an update view.
Montone RA; Niccoli G
Future Cardiol; 2018 Sep; 14(5):355-358. PubMed ID: 30232900
[No Abstract] [Full Text] [Related]
10. Performance of plasminogen activator inhibitor-1 as a biomarker in patients undergoing coronary angiography: Analytical and biological considerations.
Jung RG; Simard T; Di Santo P; Labinaz A; Moreland R; Duchez AC; Majeed K; Motazedian P; Rochman R; Jung Y; Hibbert B
Diab Vasc Dis Res; 2019 Sep; 16(5):478-482. PubMed ID: 31064214
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention.
Jung RG; Simard T; Di Santo P; Dhaliwal S; Sypkes C; Duchez AC; Moreland R; Taylor K; Parlow S; Visintini S; Labinaz A; Marbach J; Sarathy K; Bernick J; Joseph J; Boland P; Abdel-Razek O; Harnett DT; Ramirez FD; Hibbert B
Thromb Res; 2020 Jul; 191():125-133. PubMed ID: 32447094
[TBL] [Abstract][Full Text] [Related]
12. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
Gyöngyösi M; Glogar D; Weidinger F; Domanovits H; Laggner A; Wojta J; Zorn G; Iordanova N; Huber K
Am Heart J; 2004 Jan; 147(1):158-64. PubMed ID: 14691435
[TBL] [Abstract][Full Text] [Related]
13. Role of plasminogen activator inhibitor-1 in coronary pathophysiology.
Jung RG; Simard T; Labinaz A; Ramirez FD; Di Santo P; Motazedian P; Rochman R; Gaudet C; Faraz MA; Beanlands RSB; Hibbert B
Thromb Res; 2018 Apr; 164():54-62. PubMed ID: 29494856
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen in relation to degree and composition of coronary plaque on intravascular ultrasound in patients undergoing coronary angiography.
Buljubasic N; Akkerhuis KM; Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; de Boer SP; Regar E; van Geuns RM; Serruys PW; Boersma E; Kardys I
Coron Artery Dis; 2017 Jan; 28(1):23-32. PubMed ID: 27755007
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
